Product Information
DEXTROAMP-AMPHET ER 15 MG CAP is a generic product labeled by Prasco Laboratories, priced at $0.5570 per EA under NDC 66993059602. Its NADAC has been published 493 times since Mar 15, 2017.
FDA first approved this application on Oct 11, 2001. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
DEXTROAMP-AMPHET ER 15 MG CAP
DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, and AMPHETAMINE SULFATEStrength
3.75; 3.75; 3.75; 3.75 mg/1; mg/1; mg/1; mg/1
Manufacturer
Prasco LaboratoriesNDC
66993059602
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATEApproval Type
Authorized Generic (NDA)
FDA Application
NDA021303FDA Approved
10/11/2001
TE Code
AB1
On Market Since
4/2/2009
Pharmacological Classes
Price Statistics
The NADAC for DEXTROAMP-AMPHET ER 15 MG CAP has been published 493 times since Mar 15, 2017, and over the history we have for it it has declined 81.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5570 per EA |
|---|---|
| All-time high | $2.9757 (Mar 15, 2017) |
| All-time low | $0.4362 (May 22, 2024) |
| 52-week high | $0.5766 |
| 52-week low | $0.5015 |
| Median price | $0.6897 |
| Average price | $1.1389 |
| Largest weekly change | +45.9% (Aug 21, 2024) |
| Weeks tracked | 493 |
| Tracking since | Mar 15, 2017 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 4% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DEXTROAMP-AMPHET ER 15 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for DEXTROAMP-AMPHET ER 15 MG CAP, manufactured by Prasco Laboratories, is $0.5570 per EA (NDC 66993059602), effective Aug 19, 2026.
How has the price of DEXTROAMP-AMPHET ER 15 MG CAP changed over time?
Over the history we have for it, the NADAC for DEXTROAMP-AMPHET ER 15 MG CAP has declined 81.3%. It has been tracked across 493 weekly CMS publications since Mar 15, 2017.
What are the highest and lowest recorded NADAC prices for DEXTROAMP-AMPHET ER 15 MG CAP?
Since Mar 15, 2017, the NADAC for DEXTROAMP-AMPHET ER 15 MG CAP has ranged from a low of $0.4362 (May 22, 2024) to a high of $2.9757 (Mar 15, 2017), with a median of $0.6897 per EA.
Are there cheaper alternatives to DEXTROAMP-AMPHET ER 15 MG CAP?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DEXTROAMP-AMPHET ER 15 MG CAP, is $0.5323 per EA — about 4% below DEXTROAMP-AMPHET ER 15 MG CAP.
Who manufactures DEXTROAMP-AMPHET ER 15 MG CAP?
DEXTROAMP-AMPHET ER 15 MG CAP (NDC 66993059602) is labeled by Prasco Laboratories, and CMS classifies it as a generic product.